In the attempt to discover the relationship between IL-6, SARS-CoV-2 infection and CD, it can be said that, after the onset of infection, the release of IL-6 as a proinflammatory marker is beneficial in controlling viral infection and bacterial complications. This evidence concerns the gene IL6 and viral infectious disease.